|
Á¦À̵å¸ÞµðÄ® |
±¹³»¿µ¾÷»ç¿ø
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
08.28 |
|
|
´ºÆ®¶ó¼öƼÄà |
°Ç°°ü¸® ¿¹¹æ ÄÁ¼³ÅÏÆ®
¼¿ï ÀüÁö¿ª, °æ±â ÀüÁö¿ª | Çз¹«°ü |
¼ö½Ãä¿ë |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
06.29 |
|
|
È÷¾î´åÄÄÄÚ¸®¾Æ |
º¸Ã»±â ¼¼ÀÏÁî ÄÁ¼³ÅÏÆ®(¿µ¾÷/°í°´»ó´ã)¸ðÁý
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
04.04 |
|
|
ÄܹÙÅØÄÚ¸®¾Æ À¯ÇÑȸ»ç |
ÄܹÙÅØÄÚ¸®¾Æ »ç¹«º¸Á¶ °è¾àÁ÷/ÀÎÅÏÁ÷ ä¿ë(½ÅÀÔ)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ç¹«/Ãѹ«/¹ý¹«/ƯÇã |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.26 |
|
|
Äھƿ¥ |
RA ½Å±Ô ¸ðÁýÇÕ´Ï´Ù.
¼¿ï ¿µµîÆ÷±¸ | Çз¹«°ü |
¼ö½Ãä¿ë |
°æ·Â¹«°ü |
ä¿ë½Ã |
03.13 |
|
|
¾ÆÀÌÄÜŬ¸®´ÏÄø®¼Ä¡ |
Entry level Clinical Research Associate (CRA) ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.05 |
|
|
¾¾¿£¾Ë¸®¼Ä¡ |
[¾¾¿£¾Ë¸®¼Ä¡] ¿µ¹® µ¥ÀÌÅÍ ÀÔ·Â »ç¹«º¸Á¶ Part Timert ä
¼¿ï °³²±¸ | Çз¹«°ü |
»ç¹«/Ãѹ«/¹ý¹«/ƯÇã |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.14 |
|
|
Pentax Medical |
[PENTAX Medical] ³»½Ã°æ Filed Engineer/Service Sales
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
03.31 |
|
|
½Ã¹ÍÄÚ¸®¾Æ |
[½Ã¹ÍÄÚ¸®¾Æ] Senior Medical Writer ä¿ë
¼¿ï °³²±¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
09.10 |
|
|
Veeva Systems Korea YH |
Senior Consultant - R&D Vault
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
04.24 |
|
|
Veeva Systems Korea YH |
CRM Consultant
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
04.24 |
|
|
Veeva Systems Korea YH |
Account Executive - R&D Vault
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
04.24 |
|
|
Veeva Systems Korea YH |
Solution Consultant - Vault R&D
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
04.24 |
|
|
Veeva Systems Korea YH |
Product Manager
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
¼ö½Ãä¿ë |
°æ·Â¹«°ü |
ä¿ë½Ã |
04.24 |
|
|
(ÁÖ)ÇöÀÏ·¦¼Ö·ç¼Ç |
º´¿ø ¹× ´ëÇб³ ¹è¼Û, ³³Ç° Á¤±ÔÁ÷ ä¿ë - °æ·Â&½ÅÀÔ
¼¿ï ¸¶Æ÷±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¹è¼Û/³³Ç°/¿îÀü±â»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
03.23 |
|